© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Omid Hamid, MD, discusses sequencing and combining targeted therapies in the treatment of melanoma.
Omid Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, discusses sequencing and combining targeted therapies in the treatment of melanoma.